Abstract | BACKGROUND: Patients with rheumatoid arthritis (RA) have greater rates of cardiovascular mortality and RA is an independent cardiovascular risk factor. For the management of cholesterol, the American College of Cardiology/American Heart Association (ACC/AHA) developed new guidelines for the general population. None of the European or American guidelines are specific to RA. The European League Against Rheumatism (EULAR) recommends applying a coefficient to cardiovascular risk equations based on the characteristics of RA. Our objective was to compare the three different sets of guidelines for the eligibility of statin therapy in RA-specific population with very high risk of cardiovascular disease. METHODS AND RESULTS: We calculated the proportion of patients eligible for statins according to the guidelines of the European Society of Cardiology (ESC), the Adult Treatment Panel III ( ATP-III) and the ACC/AHA in a French cohort of statin-naïve RA patients at least 40 years age. Of the 547 women and 130 men analyzed, statins would be recommended for 9.1% of the women and 26.4% of the men, 15.6% of the women and 53.1% of the men, 38.8% of the women and 78.5% of the men, according to the ESC, ATP-III and ACC/AHA guidelines respectively. CONCLUSIONS: In RA patients, as has been observed in the general population, discordance in risk assessment and cholesterol treatment was observed between the three sets of guidelines. The use of the new ACC/AHA guidelines would expand the eligibility for statins and may be applied to RA population a condition at very high risk of cardiovascular disease.
|
Authors | Anne Tournadre, Zuzana Tatar, Bruno Pereira, Maxime Chevreau, Laure Gossec, Philippe Gaudin, Martin Soubrier, Maxime Dougados |
Journal | International journal of cardiology
(Int J Cardiol)
Vol. 183
Pg. 149-54
(Mar 15 2015)
ISSN: 1874-1754 [Electronic] Netherlands |
PMID | 25666124
(Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015. Published by Elsevier Ireland Ltd. |
Chemical References |
|
Topics |
- Adult
- Aged
- American Heart Association
- Amino Acids
(therapeutic use)
- Arthritis, Rheumatoid
(drug therapy, physiopathology)
- Cardiology
(methods, standards)
- Cardiovascular Diseases
(prevention & control)
- Cohort Studies
- Dyslipidemias
(therapy)
- Female
- France
- Humans
- Male
- Middle Aged
- Practice Guidelines as Topic
- Risk Assessment
- Risk Factors
- Risk Management
- United States
|